Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biofeedback
Launched by UNIVERSITÉ DU QUÉBEC A MONTRÉAL · Mar 10, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
\* The project explanations are in English for everyone's ease of understanding, but our study is conducted in French. \*
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have a diagnosis of TS as the main issue, as reported by the participant;
- • Be aged 14 to 21 years inclusive at the start of therapy.
- Exclusion Criteria:
- • Present a sensorimotor impairment;
- • Have a diagnosis of intellectual disability (intelligence quotient below 75);
- • Alcohol or drug abuse;
- • A neurological issue (e.g., hemifacial spasms, Huntington's disease);
- • Change medication one month or less before step 1 and up to step 4 (last measurement time) without informing a member of the research team;
- • Simultaneously receive another intervention for tics (e.g., psychologist, massage therapist) without informing a research team member.
Trial Officials
Julie Leclerc, Psychology
Principal Investigator
Université du Québec à Montréal- UQAM
Marc Lavoie, Psychology
Study Chair
Université TÉLUQ
Marie-France Marin, Psychology
Study Chair
Université du Québec à Montréal-UQAM
About Université Du Québec A Montréal
Université du Québec à Montréal (UQAM) is a leading public research university located in Montreal, Canada, renowned for its commitment to academic excellence and innovation. As a clinical trial sponsor, UQAM leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical research and improve health outcomes. The university fosters collaboration among researchers, healthcare professionals, and industry partners to conduct rigorous clinical studies that address pressing health challenges. With a strong focus on ethical practices and adherence to regulatory standards, UQAM is dedicated to contributing valuable insights to the field of medicine and enhancing patient care through evidence-based research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported